Percutaneous mitral repair with the MitraClip system in patients with mild-to-moderate and severe heart failure: A single-centre experience

Cardiovascular Therapeutics

Volumn 32, Issue 2, 2014, Pages 66-73

  Bozdag Turan, Ilkay ^a   Paranskaya, Liliya ^a   Birkemeyer, Ralf ^a   Turan, R Gökmen ^a   Kische, Stephan ^b   Akin, Ibrahim ^a   Ortak, Jasmin ^b   Stoeckicht, Yannik ^a   Schubert, Jochen ^a   Westphal, Bernd ^a   Nienaber, Christoph A ^a   Ince, Hüseyin ^b  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^b Vivantes Klinikum Friedrichshain   (Germany)

Author keywords

Clinical outcomes; Left ventricular remodeling; MitraClip; Severe heart failure

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONFIDENCE INTERVAL; ECHOCARDIOGRAPHY; FEMALE; GROIN HEMATOMA; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART SEPTUM DEFECT; HUMAN; IMPLANTABLE CLIP; IMPLANTATION; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MITRAL VALVE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MITRAL VALVE STENOSIS; MORTALITY; MULTIVARIATE ANALYSIS; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PERICARDIAL EFFUSION; PNEUMONIA; PRIORITY JOURNAL; RISK; SYSTOLIC HEART FAILURE; TREATMENT OUTCOME;

CLINICAL OUTCOMES; LEFT VENTRICULAR REMODELING; MITRACLIP; SEVERE HEART FAILURE;

MITRAL VALVE INSUFFICIENCY; AGED; AGED, 80 AND OVER; CARDIAC CATHETERIZATION; CHI-SQUARE DISTRIBUTION; FEMALE; GERMANY; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; MALE; MITRAL VALVE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RECOVERY OF FUNCTION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84896097220     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/1755-5922.12058     Document Type: Article

References (36)

1. Rosen SE, Borer JS, Hochreiter C, et al. Natural history of the asymptomatic/minimally symptomatic patient with severe mitral regurgitation secondary to mitral valve prolapse and normal right and left ventricular performance. Am J Cardiol 1994;74:374-380.
2. Ling LH, Enriquez-Sarano M, Seward JB, Tajik AJ, Schaff HV, Bailey KR, Frye RL. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 1996;335:1417-1423.
3. Trichon BH, Felker GM, Shaw LK, Cabell CH, ÒConnor CM. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 2003;91:538-543.
4. Agricola E, Ielasi A, Oppizzi M, et al. Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction. Eur J Heart Fail 2009;11:581-587.
5. Breithardt OA, Sinha AM, Schwammenthal E, Bidaoui N, Markus KU, Franke A, Stellbrink C. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 2003;41:765-770.
6. Levine HJ, Gaasch WH. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. J Am Coll Cardiol 1996;28:1083-1091.
7. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;52:e1-e142.
8. Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/ AHA 2005 guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119:e391-e479. Erratum in: Circulation. 2010; 121:e258.
9. Jamieson WR, Edwards FH, Schwartz M, Bero JW, Clark RE, Grover FL. Risk stratification for cardiac valve replacement. National Cardiac Surgery Database. Database Committee of the Society of Thoracic Surgeons. Ann Thorac Surg 1999;67:943-951.
10. O'Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2-isolated valve surgery. Ann Thorac Surg 2009;88:23-42.
11. Mirabel M, Iung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 2007;28:1358-1365.
12. Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol 2005;46:2134-2140.
13. Herrmann HC, Rohatgi S, Wasserman HS, et al. Mitral valve hemodynamic effects of percutaneous edge-to-edge repair with the MitraClip device for mitral regurgitation. Catheter Cardiovasc Interv 2006;68:821-828.
14. Herrmann HC, Kar S, Siegel R, et al. Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradient. Eurointervention 2009;4:437-442.
15. Feldman T, Kar S, Rinaldi M, et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST. J Am Coll Cardiol 2009;54:686-694.
16. Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011;364:1395-1406.
17. Siegel RJ, Biner S, Rafique AM, et al. The acute hemodynamic effects of MitraClip therapy. J Am Coll Cardiol 2011;57:1658-1665.
18. Tamburino C, Ussia GP, Maisano F, et al. Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting. Eur Heart J 2010;31:1382-1389.
19. Franzen O, Baldus S, Rudolph V, et al. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 2010;31:1373-1381.
20. ® system: perioperative and 1-year follow-up results using standard or multiple clipping strategy. Catheter Cardiovasc Interv 2013;81:1224-1231.
21. Paranskaya L, D'Ancona G, Bozdag-Turan I, et al. Percutaneous vs surgical repair of mitral valve regurgitation: single institution early and midterm outcomes. Can J Cardiol 2012;29:452-459.
22. ® system is a risk factor for adverse one-year outcome. Catheter Cardiovasc Interv 2013;81:609-617.
23. ®: comparative analysis of different EuroSCORE strata. EuroIntervention 2012;8:571-578.
24. Auricchio A, Schillinger W, Meyer S, et al. Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling. J Am Coll Cardiol 2011;58:2183-2189.
25. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84-e231.
26. Roques F, Michel P, Goldstone AR, Nashef SA. The logistic Euro- SCORE. Eur Heart J 2003;24:882-883.
27. O'Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2-isolated valve surgery. Ann Thorac Surg 2009;88:S23-S42.
28. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777-802.
29. Foster E, Wasserman HS, Gray W, et al. Quantitative assessment of severity of mitral regurgitation by serial echocardiography in a multicenter clinical trial of percutaneous mitral valve repair. Am J Cardiol 2007;100:1577-1583.
30. Rudolph V, Knap M, Franzen O, et al. Echocardiographic and clinical outcomes of MitraClip therapy in patients not amenable to surgery. J Am Coll Cardiol 2011;58:2190-2195.
31. Braun J, Bax JJ, Versteegh MI, et al. Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in ischemic mitral regurgitation. Eur J Cardiothorac Surg 2005;27:847-853.
32. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 2005;45:381-387.
33. McGee EC, Gillinov AM, Blackstone EH, et al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2004;128:916-924.
34. Mihaljevic T, Lam BK, Rajeswaran J, et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol 2007;49:2191-2201.
35. ® therapy in patients with end-stage systolic heart failure. Eur J Heart Fail 2011;13:569-576.
36. Neuss M, Schau T, Schoepp M, Seifert M, Hölschermann F, Meyhöfer J, Butter C. Patient selection criteria and midterm clinical outcome for MitraClip therapy in patients with severe mitral regurgitation and severe congestive heart failure. Eur J Heart Fail 2013;15:786-795.